GGrantIndex
Sort

51,570 grants matching autoimmune disease

NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)

$1,200,000
Anbu Devasahayam · · N01 · FY2023 · AI

Prepubertal Stress, Windows of Risk & Sex Bias for Affective Disturbance

$1,200,000
Cynthia Neill Epperson · University Of Pennsylvania · P50 · FY2014 · MH

Structure-Function Analyses of Plant NLR receptors

$1,200,000
Jeffery L Dangl · University Of North Carolina At Chapel Hill · · FY2018 · BIO

A Multi-Center Group to Study Acute Liver Failure in Children

$1,199,645
Robert H Squires · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · DK

NIAMS Multidiciplinary Clinical Research Center

$1,199,176
Children'S Hospital Med Ctr (Cincinnati) · P60 · FY2001 · AR

Diabetes Endocrinology Research Center

$1,198,886
University Of Virginia Charlottesville · P30 · FY2003 · DK

Cytokines and T Cell Development

$1,198,875
Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Lymphoma Disease Discovery and Definition

$1,198,546
Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA

Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease

$1,198,466
Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE

Nuclear receptors: action, functions, and roles in disease

$1,197,737
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

Protein Modifications Involved in Cell Signaling

$1,196,889
Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Virome and Immune Responses associated with IA and Type 1 Diabetes

$1,195,882
Richard E Lloyd · Baylor College Of Medicine · R01 · FY2024 · DK

Genetic and Environmental Modifiers Of Autoimmune Disease

$1,195,579
Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

PATHOPHYSIOLOGY OF HTLV1 AND HTLVII INFECTION

$1,195,459
University Of California San Francisco · R01 · FY2002 · HL

Genes for Tolerance and Immunity Consortium

$1,194,476
Australian National University · R01 · FY2003 · AI

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,194,199
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

A Controlled Trial of CBT for Multiple Sclerosis Inflammation

$1,193,863
David I. Daikh · Northern California Institute/Res/Edu · R01 · FY2007 · HD

Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk

$1,193,316
Yousin Suh · Columbia University Health Sciences · R01 · FY2020 · DK

Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

$1,192,518
Hubert M Tse · University Of Kansas Medical Center · R01 · FY2023 · DK

Immune Function and the Progression to Type 1 Diabetes

$1,192,398
Mark A Atkinson · University Of Florida · P01 · FY2015 · AI

Immune Function and the Progression to Type 1 Diabetes

$1,192,397
Mark A Atkinson · University Of Florida · P01 · FY2017 · AI

Immune Function and the Progression to Type 1 Diabetes

$1,191,074
Mark A Atkinson · University Of Florida · P01 · FY2014 · AI

Factors Influencing Genetic Transcription Initiation And Termination

$1,190,858
Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia

$1,190,603
Bronwen Shaw · Medical College Of Wisconsin · U24 · FY2024 · HL

Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

$1,190,423
Hubert M Tse · University Of Alabama At Birmingham · R01 · FY2020 · DK